Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy Adults

12 de novembro de 2026 atualizado por: Driscoll's

This is a decentralized, single-arm, within-subject crossover clinical study evaluating the effects of Driscoll's Raspberries and Driscoll's Blackberries on postprandial glycemic response, satiety, and consumer appeal in healthy adults aged 18-65 years. Forty participants will each consume three standardized breakfast meals - a raspberry-inclusive meal, a blackberry-inclusive meal, and a sugar-reference meal - in any order over a two-week period, wearing a continuous glucose monitor (CGM) throughout.

All study activities are conducted remotely at participants' homes. CGM data will be used to compute incremental area under the glucose-time curve (iAUC) over the two-hour postprandial window following each meal. Self-reported questionnaires will assess satiety, energy, digestive comfort, and sensory appeal following each meal condition.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Estimado)

40

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Nevada
      • Las Vegas, Nevada, Estados Unidos, 89101
        • Citruslabs

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 65 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Be male or female.
  • Adult aged 18-65 years.
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
  • Willing and able to wear a CGM device continuously for the two-week study period.
  • Willing to consume three standardized breakfast meals over the two-week study period, each consumed after an overnight fast of at least eight hours, with a minimum of 24 hours between each standardized meal event.
  • Willing to purchase and eat fresh Driscoll's Raspberries and Driscoll's Blackberries from a local retailer using a sponsor-provided berry stipend for use in the standardized meals.
  • Have reasonable access to a retailer that sells Driscoll's-branded raspberries and blackberries.
  • Have access to a smartphone or computer with a reliable internet connection.
  • Willing to maintain the same diet and exercise regimen consistently throughout the study duration.
  • Willing and able to complete all required digital surveys via the Citruslabs study platform at Baseline, and at the end of the day following Meal 1, Meal 2, and Meal 3.
  • Resides in the United States.

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
  • Anyone currently undergoing treatment for cancer, or have had a serious illness requiring hospitalization in the last 3 months.
  • Known or suspected allergy or hypersensitivity to raspberries, blackberries, or other berry species.
  • Known or suspected allergy, intolerance, or sensitivity to oats or gluten that would prevent consumption of the standardized oat-based meal component.
  • Current diagnosis of type 1 diabetes, type 2 diabetes, or prediabetes.
  • Current use of any medications or supplements known to significantly affect blood glucose levels, including but not limited to: insulin, metformin, GLP-1 receptor agonists, SGLT-2 inhibitors, sulfonylureas, or other glucose-lowering agents.
  • Known skin sensitivity to adhesives or prior documented adverse reaction to CGM sensors or similar transcutaneous monitoring devices.
  • Presence of implanted electronic devices (e.g., pacemaker, implantable cardioverter-defibrillator) that may be contraindicated with CGM device use, per the CGM manufacturer's specifications.
  • Pregnant, breastfeeding, or planning to become pregnant during the study period.
  • Anyone with a history of substance abuse.
  • Anyone who is currently a smoker or has been a smoker in the past three months.
  • Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.
  • History of an eating disorder currently requiring active clinical treatment.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Driscoll's Blackberries Arm

All participants complete all three meal conditions in any sequence.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Incremental Area Under the Glucose-Time Curve (iAUC) - Raspberry Meal vs. Sugar-Reference Meal
Prazo: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of raspberry meal vs. sugar-reference meal

Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
Incremental Area Under the Glucose-Time Curve (iAUC) - Blackberry Meal vs. Sugar-Reference Meal
Prazo: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of blackberry meal vs. sugar-reference meal

Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in Self-Reported Hunger
Prazo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Fullness
Prazo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Desire to Eat
Prazo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Energy Levels
Prazo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Digestive Comfort
Prazo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Bloating
Prazo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Perceived Sweetness of Meal
Prazo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Palatability of Meal
Prazo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Motivation to Eat Healthier the Rest of the Day
Prazo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Overall Acceptability of Meal
Prazo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de novembro de 2026

Conclusão Primária (Estimado)

1 de dezembro de 2026

Conclusão do estudo (Estimado)

1 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

12 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

12 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • DRISC-40019

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .